EWP
GILD icon

Engrave Wealth Partners’s Gilead Sciences GILD Stock Holding History

Engrave Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-460
Closed -$29K – 439
2019
Q4 		$29K Buy
+460
New +$30K 0.03% 181

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Engrave Wealth Partners's GILD Position: Q1 2020 in Review

Engrave Wealth Partners sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 460 shares — an estimated $29K sold.

Engrave Wealth Partners first reported a position in GILD in Q4 2019 and held it in 1 quarter. The position peaked at $29K in Q4 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Engrave Wealth Partners reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 460 Gilead Sciences shares in Q1 2020, an estimated $29K.
  • Engrave Wealth Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 1 quarter.
  • Engrave Wealth Partners's Gilead Sciences position peaked at $29K in Q4 2019.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Engrave Wealth Partners's 13F filing for Q1 2020, filed 20 Apr 2020.